---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-008924"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T17:56:42.138279+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Rhythm stockholders elect two Class II directors, approve officer exculpation amendment

## Summary
- Jennifer Good (55.6M votes for) and Edward T. Mathers (35.2M for) elected as Class II directors.
- Ernst & Young ratified as independent auditor for FY2025 with 60.6M votes for, 158k against.
- Non-binding advisory vote on executive compensation approved (40.9M for, 18.1M against).
- Amendment to certificate of incorporation to provide officer exculpation approved (55.5M for, 3.5M against).

## SEC filing metadata
- accession: 0001558370-25-008924
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000155837025008924/0001558370-25-008924-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000155837025008924/rytm-20250624x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-008924
- JSON: https://secwatch.observer/filing/0001558370-25-008924.json
- Plain text: https://secwatch.observer/filing/0001558370-25-008924.txt

## Key facts
- Governance Changes
  RHYTHM PHARMACEUTICALS, INC.: Amended certificate of incorporation to provide for officer exculpation from fiduciary duty breaches to the fullest extent permitted by Delaware law (effective 2025-06-25).
  - Change: charter amendment
  - Effective: 2025-06-25
  source text: On June 24, 2025 Rhythm Pharmaceuticals, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”), which had previously been adopted by the Company’s Board of Directors (the “Board”) subject to stockholder approval at the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649904/000155837025008924/0001558370-25-008924-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.